ANI Pharmaceuticals Inc (ANIP)
65.43
-0.71
(-1.07%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
-0.02
(-0.03%)
After-Hours: 20:00
ANI Pharmaceuticals Cash and Short Term Investments (Quarterly): 221.12M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 221.12M |
| September 30, 2023 | 193.08M |
| June 30, 2023 | 161.71M |
| March 31, 2023 | 67.76M |
| December 31, 2022 | 48.23M |
| September 30, 2022 | 56.28M |
| June 30, 2022 | 63.38M |
| March 31, 2022 | 76.91M |
| December 31, 2021 | 100.30M |
| September 30, 2021 | 15.25M |
| June 30, 2021 | 24.26M |
| March 31, 2021 | 25.07M |
| December 31, 2020 | 7.864M |
| September 30, 2020 | 17.90M |
| June 30, 2020 | 27.70M |
| March 31, 2020 | 20.41M |
| December 31, 2019 | 62.33M |
| September 30, 2019 | 59.67M |
| June 30, 2019 | 40.59M |
| March 31, 2019 | 38.23M |
| December 31, 2018 | 43.01M |
| September 30, 2018 | 44.14M |
| June 30, 2018 | 54.99M |
| March 31, 2018 | 51.97M |
| December 31, 2017 | 31.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 18.03M |
| June 30, 2017 | 8.369M |
| March 31, 2017 | 10.83M |
| December 31, 2016 | 27.36M |
| September 30, 2016 | 16.16M |
| June 30, 2016 | 15.01M |
| March 31, 2016 | 77.75M |
| December 31, 2015 | 154.68M |
| September 30, 2015 | 150.91M |
| June 30, 2015 | 166.73M |
| March 31, 2015 | 165.56M |
| December 31, 2014 | 169.04M |
| September 30, 2014 | 35.05M |
| June 30, 2014 | 52.96M |
| March 31, 2014 | 51.37M |
| December 31, 2013 | 11.10M |
| September 30, 2013 | 10.93M |
| June 30, 2013 | 12.59M |
| March 31, 2013 | 29.39M |
| December 31, 2012 | 34.79M |
| September 30, 2012 | 38.05M |
| June 30, 2012 | 42.42M |
| March 31, 2012 | 49.47M |
| December 31, 2011 | 57.23M |
| September 30, 2011 | 69.60M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
7.864M
Minimum
Dec 2020
221.12M
Maximum
Dec 2023
67.89M
Average
56.28M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 170.31M |
| ADMA Biologics Inc | 51.35M |
| Dentsply Sirona Inc | 334.00M |
| Allogene Therapeutics Inc | 448.70M |
| Vanda Pharmaceuticals Inc | 388.26M |